---
template: spec-retrospective
purpose: "Stage 5 structured self-evaluation of the Stage 4 specification, surfaced from cold-LLM execution evidence and manual verification"
author: Truc Pham
date: 2026-05-17
company: Apple Inc. (AAPL)
fiscal_period: FY2025
stage: 5
parent_spec: docs/specs/2026-05-17-pham-apple-spec.md
parent_llm_output: deliverables/2026-05-17-pham-apple-llm-raw.md
parent_verification: analysis/validation/2026-05-17-pham-apple-stage5-verification.md
parent_final_analysis: deliverables/2026-05-17-pham-apple-final-analysis.md
status: FINAL — Stage 5 retrospective deliverable
---

# Stage 4 Spec Retrospective — Apple Inc. Analysis

**Author:** Truc Pham
**Date:** 2026-05-17
**Parent spec:** `docs/specs/2026-05-17-pham-apple-spec.md` (Apple Inc. FY2025 ratio analysis)

This retrospective evaluates the Stage 4 specification against the symptoms observed in the cold-LLM execution (Stage 5 raw output) and the manual ratio verification. It is the structured self-assessment required by the Stage 5 brief — 25% of the stage grade.

---

## 1. Section-by-Section Verdict

The Stage 4 spec is composed of two parts and eleven sections. Each is rated **Clear**, **Vague**, or **Missing**, with the specific symptom in the Stage 5 output that justifies the rating.

| Spec Section | Verdict | Symptom in Stage 5 Output |
|---|---|---|
| Part A.1 Scope & Objective | **Clear** | LLM correctly identified Apple FY2025 GAAP, USD millions, audited by EY, and reproduced the analytical objective verbatim in its opening paragraph. No drift on scope. |
| Part A.2 Model Architecture | **Clear** | LLM understood the six-tab layout, color convention, and the year-suffix mapping (§2.3) — no `#REF!` errors and no `yearCurrent` confusion. The HIL iteration from Stage 4 paid off here. |
| Part A.3 Data Inputs | **Vague** | LLM grouped share price ($255.46), shares outstanding (14,773.26M), and cost of capital (8.5%) under a single "Analyst assumptions" heading. Share price and shares outstanding are NASDAQ-disclosed and 10-K-disclosed respectively; only cost of capital is a derived analyst input. The spec did not distinguish disclosed-vs-derived market data and the LLM faithfully repeated the conflation. **This is Gap #1 below.** |
| Part A.4 Named Range Conventions | **Clear** | LLM used named-range notation in every formula it referenced (e.g., `INC_net / startYear_equity`). No cell-address contamination. The convention block in §4 was effective. |
| Part A.5 Derived Inputs | **Clear** | LLM correctly computed NOPAT, average balances, daily sales/COGS, and the working-capital denominator. Each derived input was used as the spec defined it. |
| Part A.6 Ratio Definitions & Formulas | **Clear** | LLM produced 5/5 manually-verified ratios with exact-match values. Formula recall was perfect across all six categories. |
| Part A.7 Validation Rules | **Clear** (with one nuance) | LLM correctly applied the ±2pp Du Pont ROE tolerance to flag the 47-point Direct-vs-Du Pont gap as a *structural* mismatch rather than an arithmetic error. The validation tolerance was the right design choice. |
| Part B.8 Analysis Requirements | **Vague (two sub-gaps)** | (a) §8.2 asked for ROA but the LLM reported only start-of-year ROA prominently; the average variant appeared as a parenthetical without ranking. (b) §8.4 did not specify how to interpret degenerate solvency ratios (TIE = n/a when interest = $0); the LLM handled it through its own analytical maturity. **This is Gap #2 below.** |
| Part B.9 Du Pont Decomposition | **Vague** | LLM correctly executed the decomposition but the spec did not specify *which* ROE (Direct vs. Du Pont) should be "headlined" in interpretive prose. The LLM reported both 196.68% and 149.52% side-by-side without ranking, which would confuse a board-level reader. **This is Gap #3 below** — the single most consequential gap. |
| Part B.10 Strategic Recommendations | **Vague** | Spec required 3-5 recommendations with ratio evidence and trade-off acknowledgments, and LLM delivered them — but spec did not require peer benchmarking. As a result, the LLM's recommendations cited absolute targets (e.g., "current ratio floor of 0.85") without anchoring to peer levels (MSFT, GOOGL, META), which weakens defensibility. **This is Gap #4 below.** |
| Part B.11 Output Format | **Clear** | LLM produced the exact section structure (Executive Summary, Company & Data Summary, six ratio sections, Du Pont, Strategic Recommendations, Validation Notes, References) within the word-count targets. Format compliance was 100%. |

**Summary verdict counts:** 8 sections **Clear**, 4 sections **Vague**, 0 sections **Missing**. The spec is foundationally sound — the LLM produced a defensible analysis — but four framing and reporting gaps materially weakened the analytical output.

---

## 2. Top 3 Gaps with Evidence (Plus One Additional)

### Gap #1 — Conflation of Disclosed Data and Analyst Assumptions (§3.3)

**Where it surfaced.** In the LLM's "Company & Data Summary" section: *"Analyst assumptions: share price $255.46 (FY2025 close), shares outstanding 14,773.26M, cost of capital 8.5%, effective tax rate 15.6%."* All four items were grouped under the same "analyst assumption" heading despite three of them being directly disclosed (share price from NASDAQ, shares outstanding from the 10-K weighted-average disclosure, and effective tax rate computable directly from disclosed pretax income and tax provision).

**What my spec caused.** Stage 4 spec §3.3 listed all market and analyst inputs in a single table titled "Market & assumption inputs" — implicitly treating them as a single category. The cold LLM, with no other context, treated the entire table as analyst-derived. A category mistake at this level cascades through the analysis: a reader who trusts "analyst assumption" interpretation may discount the share-price-based MVA and M/B ratios as estimates rather than market-disclosed facts.

**Exact spec language I would add.** Replace §3.3 with two separate tables:

```
### 3.3 Market & Disclosed Data (from external sources)

| Name | Description | Source | Value | Unit |
|---|---|---|---|---|
| share_price | AAPL closing price, FYE Sep 26, 2025 | NASDAQ disclosed | 255.46 | USD/share |
| shares_outstanding | Diluted weighted-average shares, FY2025 | 10-K Income Statement note | 14,773.26 | M shares |
| effective_tax_rate | Computed: tax provision ÷ pretax income | Derived from 10-K | 0.1561 | decimal |

### 3.4 Analyst-Derived Inputs (not disclosed)

| Name | Description | Source | Value | Unit |
|---|---|---|---|---|
| cost_capital | CAPM-derived WACC (see §3.5 derivation) | External | 0.085 | decimal |
```

**Why this fix matters.** Cleanly separating observed market data from derived analyst estimates is a fundamental data-discipline skill. The fix takes 90 seconds in the spec but prevents an LLM (or any downstream reader) from mis-classifying the analytical evidence base.

### Gap #2 — Undefined Handling of Degenerate Solvency Ratios (§8.4)

**Where it surfaced.** In the LLM's Leverage Ratios section: *"Times Interest Earned and Cash Coverage are both n/a because reported interest expense is zero."* The LLM handled this correctly by recognizing the degenerate ratio and re-framing the underlying signal (a firm with $98.7B in gross debt and zero net interest cost is a treasury-strength signal, not missing data). But the LLM did so on its own analytical initiative — the spec gave it no guidance.

**What my spec caused.** Stage 4 §8.4 listed the seven leverage metrics and required reporting them, but said nothing about what to do when a ratio is mathematically undefined (zero denominator). A less analytically mature LLM — or a junior analyst executing the spec — could plausibly: (a) report `#DIV/0!` and flag it as a data error, (b) impute a nonzero interest expense from disclosure footnotes and produce a misleading TIE value, or (c) skip the row entirely and leave the leverage table incomplete. None of these is correct; only the LLM's chosen path (report "n/a" and re-frame the meaning) preserves the analytical signal.

**Exact spec language I would add.** Insert into §8.4:

```
**Handling degenerate solvency ratios.** When net interest expense = 0 (Apple's
FY2025 case), Times Interest Earned and Cash Coverage Ratio are mathematically
undefined. Report them as "n/a (no net interest expense)" rather than as #DIV/0!
or zero. Additionally, treat the degenerate result as a leverage signal in its own
right: a firm generating sufficient investment income to fully offset its borrowing
cost is demonstrating treasury-management capability that most peers lack. The
analysis must explicitly interpret the "n/a" — it is not missing data.
```

### Gap #3 — Du Pont ROE Headline Ambiguity (§8.6 / §9)

**Where it surfaced.** In the LLM's Du Pont Decomposition section, both Direct ROE (196.68%) and Du Pont ROE (149.52%) were reported with equal prominence: *"The Du Pont ROE (149.52%) is materially below the direct ROE (196.68%). The 47-point gap is not a calculation error..."* The LLM correctly explained the time-mismatch (Validation Check 6.3) but stopped short of telling a reader which number to use as the headline. A board-level executive reading the analysis would have to choose between two correct-but-different numbers without guidance.

**What my spec caused.** Stage 4 §8.6 ("Du Pont category") required computing the decomposition and identifying the level driver and the change driver, but did not specify which ROE figure (Direct or Du Pont) to present as the headline number in board-level communication. The two answer different questions (period-attribution vs. steady-state), and the spec left the choice to the executor. The cold LLM, lacking that guidance, reported both — which is technically correct but practically unusable for executive decision-making.

**Exact spec language I would add.** Insert into §8.6:

```
**Headline-vs-footnote convention for ROE reporting.** When Direct ROE and Du Pont
ROE diverge by more than 10 percentage points (as in Apple's FY2025 case, where
the gap is 47pp from a buyback-driven equity-base time mismatch), lead with the
Du Pont ROE in the headline narrative (the steady-state economic measure) and
report Direct ROE as a footnote (the period-historical measure). Both should
appear in the analysis; one should be designated as the headline. The criterion
for which to lead with is the analytical question being addressed: steady-state
sustainability ⇒ Du Pont; period-attribution backward-looking ⇒ Direct.
```

This is the single most consequential gap. ROE is the most frequently quoted profitability metric in executive communication, and an ambiguous headline-vs-footnote convention undermines the analysis at the moment it is most likely to be read.

### Gap #4 — No Peer-Benchmarking Requirement (§10)

**Where it surfaced.** In the LLM's Strategic Recommendations, R2 stated: *"Adopt a board-level minimum-liquidity policy (e.g., cash + securities ≥ 60 days of operating expenditures; current-ratio floor of 0.85)."* The 0.85 floor is reasonable but unanchored — why 0.85 and not 0.75 or 0.95? The same critique applies to R3's $50B book-equity floor: defensible but unbenchmarked.

**What my spec caused.** Stage 4 §10 listed five requirements for recommendations (ratio evidence, direction-specific verb, quantification, trade-off acknowledgment, FY2026 horizon) but did not require peer-benchmarking. Without a peer cohort, absolute targets float without justification, weakening the defensibility of the recommendation.

**Exact spec language I would add.** Add a sixth requirement to §10:

```
6. **Anchored to named peers where possible.** Where the recommendation includes
   a quantified target (e.g., "current ratio floor of 0.85"), cite at least one
   peer firm and its corresponding ratio level (e.g., "consistent with MSFT's
   FY2025 current ratio of 1.27 adjusted for [reason], or below GOOGL's 1.84
   reflecting Apple's distinct working-capital model"). If no peer benchmarking
   is feasible (e.g., for a uniquely positioned firm), state so explicitly with
   one sentence of justification.
```

This is the spec gap most easily-fixed by adding a peer-data section to the Data Inputs (§3) and requiring its use in §10.

---

## 3. Three Revisions (Tied to Gaps)

| # | Revision | Ties to Gap # | Estimated effort |
|---|---|---|---|
| 1 | Split §3.3 into §3.3 (Market & Disclosed Data) and §3.4 (Analyst-Derived Inputs). Apply the language drafted in Gap #1 above. | Gap #1 | 5 min in spec, prevents categorical misclassification downstream |
| 2 | Add the "Handling degenerate solvency ratios" paragraph to §8.4 with explicit instructions to report "n/a" and interpret the result. | Gap #2 | 10 min in spec, prevents `#DIV/0!` or imputation errors |
| 3 | Add the "Headline-vs-footnote convention for ROE reporting" paragraph to §8.6, with the >10pp divergence trigger and the steady-state-vs-period-attribution criterion for choosing between Direct and Du Pont ROE. | Gap #3 | 15 min in spec, fixes the most consequential framing gap |

A fourth revision (peer-benchmarking requirement in §10, Gap #4) would also be valuable but requires adding a peer-cohort data section to §3, which is a larger scope expansion. I would defer it to a v2.0 spec rather than include it in the immediate revision pass.

---

## 4. Effectiveness Rating

**Rating: 4 / 5**

**Justification.** The Stage 4 spec succeeded at the foundational tasks: the cold LLM produced a defensible, comprehensive analysis with mathematically perfect ratio computations, structurally compliant output, and intelligent handling of Apple's anomalies. The Stage 4 HIL iteration on year conventions paid off — there were zero `#REF!` errors and no FY2024-vs-FY2025 confusion across 25+ ratios. These are non-trivial achievements; many specs fail at exactly these points and require multiple round-trips to debug.

What separates the spec from a 5/5 score is the four framing and reporting gaps identified above — none of them caused arithmetic failures, but together they meant the LLM's analytical output required visible human revision in three places (Gap #1's data classification correction, Gap #3's ROE headline choice, Gap #4's missing peer benchmarking) before it could function as an executive deliverable. A 5/5 spec would have produced an analysis requiring only stylistic editing, not categorical correction.

**Anchor points (for reference):**
- 1/5: Spec failed broadly — LLM could not produce defensible output. Multiple `#REF!` errors, conventions ignored, recommendations missing.
- 3/5: Spec workable — LLM produced output with multiple gaps requiring significant rework before usable.
- 4/5: Spec strong — LLM produced output with framing/reporting gaps requiring targeted human revision (this case).
- 5/5: Spec excellent — LLM output required only stylistic editing; analytical substance was complete.

I am rating my own spec 4/5 with confidence. The rating could plausibly be a 3.5/5 if the four gaps were weighted heavily, but I think the strength of the foundational elements (named-range discipline, validation rules, output format compliance) earns the higher anchor.

---

## 5. Forward Link — What Changes for the Next Spec

The principle I extracted from this retrospective: **a strong spec answers not just "what to compute" but also "what to do when the computation is degenerate, ambiguous, or requires categorical judgment."**

The Stage 4 spec was strong on the first half ("what to compute") and weak on the second half ("what to do at the edges"). For my next spec — whether for a different ratio analysis, a different financial model, or a different domain entirely — I will add a dedicated "Edge Cases and Categorical Conventions" section that explicitly handles:

1. **Disclosed-vs-derived data distinctions** (the Gap #1 lesson)
2. **Degenerate or undefined computational results** (the Gap #2 lesson)
3. **Multiple correct answers requiring a headline-choice criterion** (the Gap #3 lesson)
4. **Comparable-benchmarking requirements when absolute targets are proposed** (the Gap #4 lesson)

These four edge-case categories are not domain-specific — they would apply to a working-capital model, a valuation spec, a credit-scoring spec, or any analytical artifact where multiple correct answers can coexist. Building this section into every future spec is the single most leveraged habit-change from this retrospective.

---

## 6. Retrospective Process Feedback (≤150 words)

The retrospective template asks for verdict, evidence, gaps, revisions, rating, and forward link — all of which I produced. One structural enhancement would meaningfully improve the template: **add a separate "Severity × Frequency Matrix" for the identified gaps.** Currently, all three gaps are treated as equally weighted "Top 3" items. In practice, Gap #3 (Du Pont ROE headline) is high-severity and high-frequency (ROE is reported in nearly every executive deliverable), Gap #4 (peer benchmarking) is medium-severity and high-frequency, and Gap #1 (disclosed-vs-derived) is medium-severity and low-frequency (it affects only the data-summary section once). A matrix would help future authors prioritize which gaps to fix first when spec-revision time is scarce.

**Suggested addition to the template:**
```
## Gap Prioritization Matrix
| Gap # | Severity (1-3) | Frequency (1-3) | Priority Score (Sev × Freq) |
```

---

*Retrospective compiled by Truc Pham, 2026-05-17. Foundational evidence: cold-LLM output (Stage 5 Step 1), manual verification (Step 2), and the final analysis (Step 3). All four gaps identified in §2 were surfaced empirically — none were anticipated when the Stage 4 spec was authored.*
